Cold & Cough Remedies (Pharmacies) - Belarus

  • Belarus
  • Revenue in the Cold & Cough Remedies market is projected to reach US$1,117.00m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 7.18%, resulting in a market volume of US$1,580.00m by 2029.
  • In global comparison, most revenue will be generated in China (US$7,826.00m in 2024).
  • In relation to total population figures, per person revenues of US$118.20 are generated in 2024.

Key regions: Canada, United Kingdom, United States, China, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies (Pharmacies) market in Belarus has been experiencing steady growth in recent years.

Customer preferences:
Belarus has a high prevalence of cold and cough-related illnesses, which has led to a strong demand for remedies in the market. Customers in Belarus prefer over-the-counter cold and cough remedies that are easily accessible in pharmacies. They value convenience and affordability when choosing remedies for their symptoms.

Trends in the market:
One noticeable trend in the Cold & Cough Remedies market in Belarus is the increasing popularity of natural and herbal remedies. Customers are becoming more health-conscious and are seeking alternatives to traditional pharmaceutical products. This trend is in line with the global shift towards natural and organic remedies. As a result, there has been a rise in the availability of natural cold and cough remedies in pharmacies across Belarus. Another trend in the market is the growing demand for combination remedies. Customers prefer products that offer multiple benefits, such as relieving both cold and cough symptoms. Combination remedies provide convenience and cost-effectiveness, as customers only need to purchase one product instead of multiple individual remedies. This trend is driven by the desire for simplicity and efficiency in managing cold and cough symptoms.

Local special circumstances:
Belarus has a well-established pharmaceutical industry, which ensures a steady supply of cold and cough remedies in the market. The country has a robust network of pharmacies, making these remedies easily accessible to customers. Additionally, the government in Belarus has implemented regulations to ensure the quality and safety of pharmaceutical products, including cold and cough remedies. These regulations provide customers with confidence in the effectiveness and reliability of the remedies available in pharmacies.

Underlying macroeconomic factors:
The growing Cold & Cough Remedies market in Belarus can be attributed to several macroeconomic factors. Firstly, the increasing disposable income of the population has allowed customers to spend more on healthcare products, including remedies for cold and cough symptoms. This rise in disposable income has also contributed to the affordability of these remedies, making them accessible to a larger segment of the population. Furthermore, the aging population in Belarus has led to a higher demand for cold and cough remedies. Older individuals are more susceptible to cold and cough-related illnesses, and they often require remedies to manage their symptoms. The aging population trend is expected to continue, further driving the growth of the Cold & Cough Remedies market in Belarus. In conclusion, the Cold & Cough Remedies market in Belarus is developing steadily due to customer preferences for accessible and affordable remedies, the increasing popularity of natural and herbal remedies, and the demand for combination remedies. The local special circumstances, such as a well-established pharmaceutical industry and government regulations, contribute to the growth of the market. Underlying macroeconomic factors, such as increasing disposable income and an aging population, also play a significant role in the development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)